APA

Hiransuthikul A., Thammajaruk N., Techatanawat I., Karachot B., Chuasuwan B., Manamuti C., Duereh M., Sawpitiporn M., Sophonphan J., Gatechompol S., Avihingsanon A., Bowonwattanuwong C. & Ruxrungtham K. (20190930). Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults. : Antiviral therapy.

Chicago

Hiransuthikul Akarin, Thammajaruk Narukjaporn, Techatanawat Isariya, Karachot Busarat, Chuasuwan Bancha, Manamuti Chutima, Duereh Mariam, Sawpitiporn Mathus, Sophonphan Jiratchaya, Gatechompol Sivaporn, Avihingsanon Anchalee, Bowonwattanuwong Chureeratana and Ruxrungtham Kiat. 20190930. Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults. : Antiviral therapy.

Harvard

Hiransuthikul A., Thammajaruk N., Techatanawat I., Karachot B., Chuasuwan B., Manamuti C., Duereh M., Sawpitiporn M., Sophonphan J., Gatechompol S., Avihingsanon A., Bowonwattanuwong C. and Ruxrungtham K. (20190930). Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults. : Antiviral therapy.

MLA

Hiransuthikul Akarin, Thammajaruk Narukjaporn, Techatanawat Isariya, Karachot Busarat, Chuasuwan Bancha, Manamuti Chutima, Duereh Mariam, Sawpitiporn Mathus, Sophonphan Jiratchaya, Gatechompol Sivaporn, Avihingsanon Anchalee, Bowonwattanuwong Chureeratana and Ruxrungtham Kiat. Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults. : Antiviral therapy. 20190930.